A breakthrough in the fight against HIV: South Africa is preparing to roll out Lenacapavir, a long-acting HIV prevention injection taken just twice a year. It’s the latest PrEP tool in the arsenal, with trials showing high efficacy. But with HIV infection rates still alarmingly high, the rollout - slated for April 2026- faces questions of access and sustainability. This week, experts and policymakers met in Johannesburg to map the way forward. Nzinga Qunta speaks to Dr Thato Chidarikire from the World Health Organisation on what this jab could mean for South Africa’s prevention strategy Kayafm

Ver todos los episodios